Results of research in the United Kingdom suggest using E. coli vaccines in cattle could reduce the incidence of human sickness from E. coli O157 by as much as 85 percent.
click image to zoomTheir research report, titled “Predicting the public health benefit of vaccinating cattle against Escherichia coli O157,” is published in the Proceedings of the National Academy of Sciences.
The authors note that E. coli O157, which can cause serious and sometimes fatal gastrointestinal illness, is difficult to control, partly due to poor understanding of of transmission dynamics across species boundaries. Vaccines for E. coli O157 in cattle are available but not widely used for a number of reasons:
Read the full article from the journal PNAS.
- See more at: http://www.bovinevetonline.com/news/Vaccinations-could-reduce-food-borne-E-coli-incidence-224130001.html
The authors note that E. coli O157, which can cause serious and sometimes fatal gastrointestinal illness, is difficult to control, partly due to poor understanding of of transmission dynamics across species boundaries. Vaccines for E. coli O157 in cattle are available but not widely used for a number of reasons:
- Conflicting responsibilities of veterinary and public health agencies.
- Economic drivers.
- Clinical trials cannot easily test interventions across species boundaries.
- Lack of information on the public health benefits.
- Supershedding of the pathogen by cattle is associated with the genetic marker stx2.
- By quantifying the link between shedding density in cattle and human risk, we show that only the relatively rare supershedding events contribute significantly to human risk.
- This finding has profound consequences for the public health benefits of the cattle vaccine.
Read the full article from the journal PNAS.
Comentarios
Publicar un comentario